Formycon Plans Ranibizumab Filings With Ustekinumab And Aflibercept In The Wings

 
• By Aidan Fry
  
Submit
Formycon is gearing up to file its FYB201 ranibizumab biosimilar candidate for approval in the US and the EU • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products